Wells Fargo has recently downgraded its investment rating for cell therapy company ARCELLX, INC. from "Overweight" to "Equal Weight".
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
However, the institution has simultaneously raised the target stock price from $100 to $115, demonstrating recognition of the company's long-term value. This rating adjustment reflects the analysts' balanced consideration between short-term risks and long-term potential. The upward revision of the target price may be based on ARCELLX's technological advancements in the CAR-T cell therapy field or positive signals from clinical trial data.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Decoding Dogecoin’s 16% pullback: Can DOGE recover from $0.10?
AMBCrypto•2026/08/29 21:03

Polygon discloses security flaws fixed in recent hard forks
Cointelegraph•2026/08/29 20:33
Ballard names GeoPura CEO Andrew Cunningham as president, adds him and Lord Harrington to board
Reuters•2026/08/29 20:12
Ballard Power closes GBP 275 million acquisition of GeoPura
Reuters•2026/08/29 20:12
Crypto prices
MoreBitcoin
BTC
$78,123.74
+0.84%
Ethereum
ETH
$2,450.21
+0.88%
Tether USDt
USDT
$1
+0.01%
BNB
BNB
$692.54
+0.62%
XRP
XRP
$1.39
+0.97%
USDC
USDC
$1
+0.01%
Solana
SOL
$105.13
+1.38%
TRON
TRX
$0.3402
-0.51%
Hyperliquid
HYPE
$82.98
+3.73%
Dogecoin
DOGE
$0.08517
+0.29%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now